Bone Health: Biocon Biologics Receives Positive CHMP Opinions For Biosimilar Denosumab In Europe
Bangalore, India /PRNewswire/ - Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), today announced that the Committee for Medicinal Products for Human Use (CHMP) …